Tradestie Institutional Equity Comparison Engine

ATOS vs PTN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ATOS Overall Edge

ATOS Captures Institutional Edge (4โ€“0 Pillars ยท 9โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Atossa Therapeutics, Inc. Common Stock (ATOS) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, ATOS trades at 7.0x Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus PTN at 42.9x Forward P/E and -65.7% operating margin (-80.1% YoY). In options structure, ATOS sits in BREAKDOWN (37th %ile IV; Dealer Gamma Walls on Pro) against PTN sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner ATOS
ATOS 7.0x vs PTN 42.9x Fwd P/E
Growth & Margin Winner ATOS
Op Margin 0.0% vs -65.7% ยท YoY +0.0% vs -80.1%
Momentum & Technical Winner ATOS
1Y +140.4% vs -43.3% ยท 52W Pos 20% vs 6%
Options & Structure Winner ATOS
BREAKDOWN (37th %ile IV) vs UNCLASSIFIED (N/A IV)
ATOS NASDAQ
Atossa Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$1.93
-1.53% 1D
Market Cap $19.6M
1M Return -33.68%
1Y Return +140.44%
Forward P/E 7.0x
Unified AI Score
59.2 / 100 HOLD
Tech 70.0 Fund 65.0 Flow 64.0 Mom 60.0
PTN US Equity
Palatin Technologies, Inc.
Pharmaceutical Preparations
$6.12
-1.69% 1D
Market Cap $11.1M
1M Return +1.74%
1Y Return -43.29%
Forward P/E 42.9x
Unified AI Score
31.5 / 100 SELL
Tech 15.0 Fund 30.0 Flow 50.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ATOS +140.44% PTN -43.29% Spread: +183.73 pp (ATOS Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period ATOS Revenue PTN Revenue ATOS Op. Margin PTN Op. Margin Margin Edge
FY2017 N/A $70M N/A 38.6% PTN
FY2018 N/A $70M N/A 38.6% PTN
FY2019 N/A $60M N/A 59.3% PTN
FY2020 N/A $0M N/A -20007.6% PTN
FY2022 N/A $0M N/A -2491.6% PTN
FY2023 N/A $0M N/A -668.7% PTN
FY2024 N/A $0M N/A -501.0% PTN
FY2026 N/A $10M N/A -65.7% PTN

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ATOS (9) vs PTN (0)
Institutional Metric ATOS PTN Criterion Row Winner
Market Capitalization Scale $19.6M $11.1M Larger Scale Tie
Trailing P/E Ratio Valuation 7.0x 42.9x Lower Multiple ATOS
Forward P/E Ratio Valuation 7.0x 42.9x Lower Multiple ATOS
Revenue Growth (YoY) Growth +0.0% -80.1% Higher Growth ATOS
Operating Margin (TTM) Profitability 0.0% -65.7% Higher Margin ATOS
Net Profit Margin Profitability 0.0% -63.5% Higher Margin ATOS
Return on Equity (ROE) Capital Efficiency -96.9% -877.5% Higher ROE ATOS
52-Week Range Position Momentum 20% ($1โ€“$8) 6% ($5โ€“$31) Stronger Trend ATOS
Beta / 30D Volatility Risk Regime 0.35ฮฒ ยท 67% Vol 0.87ฮฒ ยท 106% Vol Lower Realized Risk ATOS
Unified Institutional Score Composite Signal 59.2 / 100 (HOLD) 31.5 / 100 (SELL) Higher Composite ATOS

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ATOS vs PTN Buy Guide
ATOS BREAKDOWN
64d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 37th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ATOS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
PTN UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live PTN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ATOS nor PTN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.